Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT01486030Completed

Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test

Role: lead

NCT01251302Completed

Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern

Role: lead

NCT00500617Completed

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

Role: lead

NCT02158754Withdrawn

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Role: lead

NCT01557855Completed

Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease

Role: lead

NCT02440893Completed

Understanding the Effect of Metformin on Corus CAD (or ASGES)

Role: lead

NCT01117506Completed

Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)

Role: lead

NCT01594411Completed

PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis

Role: lead

NCT01677156Completed

A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings

Role: lead

NCT02405754Completed

Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.

Role: lead

NCT00583297Completed

Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial

Role: lead

NCT02223286Completed

Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making

Role: lead

NCT00500708Completed

Diagnostic Investigation of Sudden Cardiac Event Risk

Role: lead

All 13 trials loaded